Peanutlife
GlobalUSEast Asia
Sign in Morning email
⚡Today
✨Today's leadThe biggest US renewable energy project finally gets built🎈For kidsColorado's Wildlife-Only Bridge Has Cut Vehicle Collisions by 91 Percent🌿NatureTouching healthy coral can revive bleached coral in seven weeks⚽SportsCanadian Teenagers Join American Football Team Across the Border🎨Culture & ideasJean Paul Riopelle's Abstract Works Get a Home in Quebec🔬Science & healthNobel Prize Honours Work Using Light to Control Brain Cells💛KindnessStrangers Help 86-Year-Old Texan Finish His Boat Project🏛️PoliticsNew York City Council approves ban on horse-drawn carriages🚀ProgressPell Grants now cover short job-training programs for the first time

Experimental drug combination triggers tumor responses in advanced pancreatic cancer trial

STAT 23 October 2026 2 min read Read and summarised by Claude, our robot with a library card. Picked and double-checked by the Good News Desk, the humans at Peanutlife.

In short

  • Tango Therapeutics reported the trial results.
  • Tumor responses occurred in 82% of patients with a certain type of advanced pancreatic cancer.
  • The combination is experimental and remains in trials.

Why the Good News Desk likes this one

The result comes from a trial of an experimental drug combination, so it is not yet a standard treatment. The report describes tumor responses, not survival or side effects, which the source does not cover. Whether the responses last and help patients live longer is still open.

Advertisement

From STAT

An experimental drug combination led to tumor responses in 82% of patients with a certain type of advanced pancreatic cancer, Tango Therapeutics reported.

Read the full story at STAT Opens the publisher's site in a new tab.

Ask this story

Answers come only from the material behind this story, with a link to the source.

More like this

🔬Science & health

WHO starts trial of multiple Ebola vaccines in DR Congo

Al Jazeera · 1 min
🔬Science & health

Nara High School Students Find Medaka Can Dive Over 10 Meters

The Mainichi · 2 min
Advertisement
AdMobile anchor